Newsroom

In The Beat Newsletter

Sign up for the CANet monthly newsletter to stay informed with our Networks activities.

Media Inquiries

Fabian Folias
Director of Digital Marketing and Communications
media@canet-nce.ca
519-661-2111 x81353

  

“Given the number of patients suffering with atrial fibrillation and the significant healthcare costs associated with managing it, there is a critical need for innovative minimally invasive cardiac procedures that improve patient outcomes without increasing healthcare costs”

Dr. Jason Andrade
Cardiology Fellow, University of Calgary and CHAT Member

Recent News

Our Current Highlights

16
Dec

CANet® is proud to announce the inaugural ‘Shift – Heart Rhythm Innovation Competition’

Toronto ON, December 16, 2019 – With the Cardiac Arrhythmia Network of Canada (CANet®) group of investigators leading ground-breaking arrhythmia health research and technology advancements, our Network is challenging startups to highlight their innovations at the inaugural CANet® Shift competition. Here’s your opportunity to showcase your innovation and win $200,000! Canadian health technology startups will...
Read More
09
Dec

Job Posting – Solutions Architect

The Cardiac Arrhythmia Network of Canada (CANet) is the gateway to arrhythmia research and development in Canada. One point of contact links pharmaceutical and biotechnology companies, government, and not-for-profit organizations to world-leading Canadian arrhythmia researchers and resources. Our vision is to generate new innovations in arrhythmia treatment and technologies that transform care, focus on the...
Read More
05
Nov

Randomized Controlled Trial Finds NRG® Transseptal Needle Leads to Shorter Procedure Times, Reduced Radiation Exposure

TORONTO, NOVEMBER 5, 2019 – A randomized controlled trial has found that use of Baylis Medical’s NRG® Transseptal Needle results in shorter time in achieving transseptal access, less transseptal attempts, and reduced exposure to radiation, compared to use of a conventional transseptal needle. The study, entitled Randomized Trial of Conventional Versus Radiofrequency Needle Transseptal Puncture...
Read More
16
Oct

Earlier the better? Intervening to halt the Progression of Atrial Fibrillation

“I am always looking for ways to help patients with atrial fibrillation lead full lives,” says Dr. Jason Andrade, University of British Columbia Cardiology Professor. He is currently leading a CANet-funded project, ‘Early Invasive vs. Delayed Intervention for Atrial Fibrillation’ which explores the first line of treatment for atrial fibrillation (AF). AF, a heart rhythm...
Read More
07
Oct

As far as eyes can see: CANet project sees old target in new light

Look once. Look twice. Look again. Drs. Frank Prato and Allan Skanes are taking no chances when it comes to improving atrial fibrillation (AF) therapies. The CANet Investigators and professors of Medicine at Western University is putting faulty heart tissues – one of the main culprits of AF – under microscopes, MRIs, X-rays, nuclear medicine...
Read More

Need More Info?

Have a story to share?


Yes, please subscribe me to the CANet newsletter